Give public the truth about vaccines

The recent announcement from the Illinois Department of Healthcare and Family Services regarding the removal of prior authorization requirements for a Respiratory Syncytial Virus (RSV) vaccine marks a significant victory in our ongoing efforts to protect vulnerable populations from respiratory disease.

HFS has taken an essential step toward improving vaccine access for those who need it most by removing the requirements for additional documentation of informed consent and prior authorization for the Abrysvo vaccine. We extend our gratitude for this important change, which will undoubtedly improve access to care and save lives.

This new policy will particularly benefit high-risk populations, including pregnant individuals during weeks 32 through 36 of pregnancy; adults aged 50 to 74 at increased risk of severe RSV disease; all adults aged 75 and older.

Respiratory Syncytial Virus is a common yet potentially severe virus that affects the lungs, leading to cold-like symptoms. While it typically resolves on its own, RSV can lead to serious complications for high-risk groups, including young children, the elderly and individuals with compromised immune systems. RSV is the most common cause of pneumonia and bronchiolitis in infants. It is critical that these groups are protected from this virus.

By streamlining access to the RSV vaccine, we can address the alarming disparities in vaccination rates that currently exist in Illinois. Recent data indicates that immunization coverage among high-risk groups is shockingly low — only 33.6% of infants under 8 months and 30.6% of adults over 75 have received the vaccine. These figures highlight a pressing need for targeted efforts to increase vaccination rates, particularly among non-Hispanic Black and Hispanic adults, as well as those with lower income and education levels.

Having better access to vaccines is a significant step forward. However, we need to go further to work alongside health care providers, community organizations and public health officials to promote vaccine literacy and outreach.

Now, let’s build on this success by continuing to educate the public with the truth about vaccines.

Erica Salem, Senior Director, Strategy, Programs & Policy

Respiratory Health Association

Chicago